Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    YXT.com

    MCap

    USD127m

    Last close

    USD23.43

    ▲ 20.23 (632.19%)

    Northern Data Group

    MCap

    EUR486m

    Last close

    EUR7.56

    ▲ 2.33 (44.59%)

    Bodycote

    MCap

    GBP1,572m

    Last close

    GBP9.23

    ▲ 173.00 (23.07%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Basilea Pharmaceutica – executive interview

Basilea Pharmaceutica – executive interview

Basilea Pharmaceutica — 12 videos in collection

More on this equity

Basilea Pharmaceutica is a Switzerland-based biopharmaceutical company, established in 2000 as a spin-out from Roche with the divestment of its anti-infective portfolio. It is listed on the SIX Swiss Stock Exchange and recently announced plans to focus strategically on anti-infectives. Revenue growth will continue to be driven from its two marketed anti-infectives, Cresemba (antifungal, for invasive mould infections) and Zevtera (antibiotic, for hospital infections). Currently, Cresemba is commercialised globally through partners such as Pfizer and Astellas. Basilea also announced plans to monetise its oncology assets (derazantinib, a pan-FGFR kinase inhibitor and lisavanbulin, a potential novel checkpoint inhibitor), which will free up resources and provide the company with incremental (financial) flexibility to fund its anti-infective strategy.

In this video, CEO David Veitch discusses the company’s anti-infective strategy.

< Previous
Next >

You may also be interested in these:

Healthcare

Basilea Pharmaceutica – executive interview

Healthcare

Basilea Pharmaceutica – executive interview
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.